News & Articles

University of California San Francisco (UCSF) uses Phenoptics™ platform to help with biomarker discovery

TrueBinding signs multi-product commercial-use license to develop stable, antibody-expressing cell lines using Horizon’s gene-edited CHO GS knockout platform

Developed with enhanced technology, this new assay provides high-quality staining with improved turnaround time

The study is the first global, randomized, double-blind, placebo-controlled phase III trial investigating Actemra/RoActemra in this setting

Find out how LC-MS technology is being used to quantify the experimental drug remdesivir

The ViroKey™ SARS-CoV-2 RT-PCR Test v2.0 is a probe-based reverse transcription PCR test

Based on the results, the U.S.-based trial has been stopped, including in a second cohort of patients who received a higher dose of Kevzara (800 mg)

Partnerships, products, and solutions facilitate detection, research, and vaccine development to combat the SARS-CoV-2 virus

The “triple antibody” test will provide health professionals with an accurate indication of the presence of IgA, IgM and IgG COVID-19 antibodies within 10 minutes

Establishing a broad range of remotely accessible COVID-19 assays including biochemical profiling for COVID-19 drug targets

Avacta to begin clinical validation of the high-throughput COVID-19 laboratory test in collaboration with the UK government CONDOR program

A new test being developed by Iceni Diagnostics promises a quick way to distinguish between the two diseases

Promega automated sample preparation solution added to CDC COVID-19 test protocol

The test is intended to expand availability of COVID-19 screening resources in central Ohio

Join us on Wednesday, August 5, to learn how in vitro models can enable a deeper understanding of T cell biology

Interim data shows strong antibody and T-cell responses in all evaluated participants

Cambridge researchers have shown how rapid genome sequencing of virus samples and enhanced testing of hospital staff can help to identify clusters of healthcare-associated COVID-19 infections

The bridging assay aims to allow a full-length trimeric Spike protein from the COVID-19 virus to be used as both a capture and detection tool

Delivers major improvements for discoveries in immunology, oncology, autoimmunity, and infectious diseases